|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 483.39 USD | -0.54% |
|
-0.27% | +6.77% |
| Market Cap | 123B 108B 99.48B 91.69B 173B 11,879B 177B 1,189B 468B 5,818B 463B 453B 20,029B | P/E 2026 * |
27.8x | P/E 2027 * | 24.5x |
|---|---|---|---|---|---|
| Enterprise Value | 110B 95.79B 88.39B 81.48B 154B 10,556B 157B 1,057B 416B 5,170B 412B 403B 17,797B | EV / Sales 2026 * |
8.4x | EV / Sales 2027 * | 7.32x |
| Free-Float |
99.8% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Vertex Pharmaceuticals Incorporated
| 1 day | -0.55% | ||
| 1 week | -0.27% | ||
| Current month | -2.55% | ||
| 1 month | +5.46% | ||
| 3 months | +9.72% | ||
| 6 months | +9.50% | ||
| Current year | +6.77% |
| 1 week | 469.6 |  | 496.69 |
| 1 month | 450.39 | | 533.67 |
| Current year | 412.27 | | 533.67 |
| 1 year | 362.5 | | 533.67 |
| 3 years | 340.2 | | 533.67 |
| 5 years | 176.36 | | 533.67 |
| 10 years | 71.46 | | 533.67 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 53 | 01/04/2020 | |
Charles Wagner
DFI | Director of Finance/CFO | 58 | 10/04/2019 |
Mark Bunnage
CTO | Chief Tech/Sci/R&D Officer | - | 01/07/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
Bruce Sachs
BRD | Director/Board Member | 66 | 01/01/1998 |
Jeffrey Leiden
CHM | Chairman | 70 | 01/05/2012 |
Sangeeta Bhatia
BRD | Director/Board Member | 57 | 18/06/2015 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 02/07/26 | Sell | Executive/Senior Manager | -1,541 | 0.0006% | ||
| 02/07/26 | Sell | Director | -1,500 | 0.0006% | ||
| 01/07/26 | Sell | General Counsel | -828 | 0.0003% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.54% | -0.27% | +4.49% | +35.22% | 123B | |
| +0.57% | -0.93% | +54.63% | +163.34% | 1,043B | |
| +0.91% | -1.84% | +54.78% | +58.58% | 602B | |
| +0.50% | +3.00% | +33.51% | +89.52% | 449B | |
| +0.78% | -0.71% | +30.04% | +24.61% | 327B | |
| +1.41% | +0.58% | +33.92% | +47.20% | 279B | |
| -0.27% | -1.87% | +22.13% | +23.47% | 264B | |
| -2.24% | +0.20% | +22.09% | +59.82% | 201B | |
| -1.15% | +3.90% | +23.98% | +74.10% | 169B | |
| -0.42% | +3.79% | +2.05% | -30.05% | 143B | |
| Average | -0.08% | -0.83% | +28.16% | +54.58% | 360.04B | |
| Weighted average by Cap. | +0.31% | -1.83% | +38.73% | +82.71% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 13.05B 11.4B 10.52B 9.7B 18.28B 1,257B 18.69B 126B 49.47B 615B 49B 47.93B 2,119B | 14.3B 12.49B 11.53B 10.63B 20.03B 1,377B 20.47B 138B 54.2B 674B 53.69B 52.51B 2,321B |
| Net income | 4.51B 3.94B 3.63B 3.35B 6.31B 434B 6.45B 43.42B 17.08B 212B 16.92B 16.55B 731B | 5.15B 4.5B 4.15B 3.83B 7.21B 496B 7.37B 49.62B 19.52B 243B 19.33B 18.91B 836B |
| Net Debt | -13.74B -12.01B -11.08B -10.22B -19.25B -1,323B -19.68B -132B -52.1B -648B -51.61B -50.48B -2,231B | -18.69B -16.33B -15.07B -13.89B -26.18B -1,799B -26.76B -180B -70.84B -881B -70.17B -68.63B -3,034B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 17/07/26 | $484.17 | -0.38% | 422,001 |
| 16/07/26 | $486.03 | +1.88% | 1,370,959 |
| 15/07/26 | $477.08 | +0.16% | 1,192,070 |
| 14/07/26 | $476.31 | -0.82% | 1,093,659 |
| 13/07/26 | $480.25 | -1.06% | 1,153,856 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- VRTX Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
